Virtus ETF Advisers’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-14,873
| Closed | -$61.3K | – | 589 |
|
|
2024
Q4 | $61.3K | Buy |
14,873
+3,092
| +26% | +$12.7K | 0.03% | 443 |
|
|
2024
Q3 | $83.4K | Buy |
11,781
+212
| +2% | +$1.5K | 0.04% | 410 |
|
|
2024
Q2 | $75.4K | Buy |
11,569
+2,867
| +33% | +$18.7K | 0.04% | 423 |
|
|
2024
Q1 | $72.2K | Sell |
8,702
-593
| -6% | -$4.92K | 0.04% | 406 |
|
|
2023
Q4 | $102K | Buy |
9,295
+1,023
| +12% | +$11.3K | 0.07% | 347 |
|
|
2023
Q3 | $69.6K | Sell |
8,272
-820
| -9% | -$6.9K | 0.04% | 386 |
|
|
2023
Q2 | $114K | Buy |
9,092
+3,306
| +57% | +$41.5K | 0.07% | 334 |
|
|
2023
Q1 | $95.3K | Sell |
5,786
-2,218
| -28% | -$36.5K | 0.05% | 347 |
|
|
2022
Q4 | $120K | Buy |
8,004
+478
| +6% | +$7.14K | 0.06% | 419 |
|
|
2022
Q3 | $168K | Buy |
7,526
+50
| +0.7% | +$1.12K | 0.07% | 339 |
|
|
2022
Q2 | $125K | Buy |
7,476
+1,918
| +35% | +$32.1K | 0.05% | 374 |
|
|
2022
Q1 | $166K | Sell |
5,558
-327
| -6% | -$9.77K | 0.07% | 212 |
|
|
2021
Q4 | $181K | Sell |
5,885
-328
| -5% | -$10.1K | 0.07% | 245 |
|
|
2021
Q3 | $196K | Sell |
6,213
-331
| -5% | -$10.4K | 0.09% | 277 |
|
|
2021
Q2 | $239K | Sell |
6,544
-305
| -4% | -$11.1K | 0.1% | 225 |
|
|
2021
Q1 | $237K | Buy |
6,849
+117
| +2% | +$4.05K | 0.1% | 298 |
|
|
2020
Q4 | $280K | Buy |
+6,732
| New | +$280K | 0.12% | 245 |
|